The study purpose is to observe which neoadjuvant chemotherapy regimens is the better for
invasive breast cancer. The neoadjuvant chemotherapy regimen is sustained anthracyclines plus
taxanes or from anthracyclines plus taxanes to vinorelbine plus cisplatinum.
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01732939
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Diagnosis of invasive ductal or lobular breast cancer.
Previously untreated (no chemotherapy or hormonal therapy or radiation therapy) invasive breast cancer.
no anti-Her2 therapy if HER2 positive ( defined as 3+ IHC or FISH positive)
Performance Status ECOG <2
Age > 18 years
Tumor > 2.0 cm by MRI and/or sonographic or clinical exam measurements.or Karnofsky
Lab test :
Absolute neutrophil count > 1,500/mm3
Total Bilirubin ≤ 2×ULN
AST and ALT ≤ 2.5×ULN
serum creatinine ≤ 1.5×ULN
Pregnant or breast feeding patients are excluded
stage Ⅳ breast cancer
History of non-breast malignancies within the 5 years prior to study entry, except for the following: carcinoma in situ of the cervix, carcinoma in situ of the colon,melanoma in situ, and basal cell and squamous cell carcinomas of the skin
uncontrolled cardiac disease
Active infection or chronic infection requiring chronic suppressive antibiotics
History of hypersensitivity reaction to investigating drugs
All locations for NCT01732939
Hospital affiliated academy military medical science
Beijing, Beijing, China, 100071
Put me in touch
View full eligibility
Tris trial is registered with FDA with number: NCT01732939. The sponsor of the trial is Hospital Affiliated to Military Medical Science, Beijing and it is looking for 60 volunteers for the current phase. Official trial title:
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!